These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7488333)

  • 1. Net uptake of plasma homocysteine by the rat kidney in vivo.
    Bostom A; Brosnan JT; Hall B; Nadeau MR; Selhub J
    Atherosclerosis; 1995 Jul; 116(1):59-62. PubMed ID: 7488333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal uptake and excretion of homocysteine in rats with acute hyperhomocysteinemia.
    House JD; Brosnan ME; Brosnan JT
    Kidney Int; 1998 Nov; 54(5):1601-7. PubMed ID: 9844136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No net renal extraction of homocysteine in fasting humans.
    van Guldener C; Donker AJ; Jakobs C; Teerlink T; de Meer K; Stehouwer CD
    Kidney Int; 1998 Jul; 54(1):166-9. PubMed ID: 9648075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homocysteine metabolism in renal failure.
    van Guldener C; Stam F; Stehouwer CD
    Kidney Int Suppl; 2001 Feb; 78():S234-7. PubMed ID: 11169017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine metabolism in renal disease.
    van Guldener C; Stehouwer CD
    Clin Chem Lab Med; 2003 Nov; 41(11):1412-7. PubMed ID: 14656019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: a case-control study.
    Bostom AG; Shemin D; Lapane KL; Miller JW; Sutherland P; Nadeau M; Seyoum E; Hartman W; Prior R; Wilson PW
    Atherosclerosis; 1995 Apr; 114(1):93-103. PubMed ID: 7605381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin B12 decreases, but does not normalize, homocysteine and methylmalonic acid in end-stage renal disease: a link with glycine metabolism and possible explanation of hyperhomocysteinemia in end-stage renal disease.
    Hyndman ME; Manns BJ; Snyder FF; Bridge PJ; Scott-Douglas NW; Fung E; Parsons HG
    Metabolism; 2003 Feb; 52(2):168-72. PubMed ID: 12601627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and its determinants in nondialyzed chronic kidney disease patients.
    Nerbass FB; Draibe SA; Feiten SF; Chiarello PG; Vannucchi H; Cuppari L
    J Am Diet Assoc; 2006 Feb; 106(2):267-70. PubMed ID: 16442876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homocysteine and renal disease.
    van Guldener C; Robinson K
    Semin Thromb Hemost; 2000; 26(3):313-24. PubMed ID: 11011849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine and methionine metabolism in renal failure.
    van Guldener C; Stehouwer CD
    Semin Vasc Med; 2005 May; 5(2):201-8. PubMed ID: 16047272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease.
    Stam F; van Guldener C; Ter Wee PM; Jakobs C; de Meer K; Stehouwer CD
    Kidney Int; 2005 Jan; 67(1):259-64. PubMed ID: 15610249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Content of total homocysteine and major aminothiols in rats with experimental renal ischemia.
    Kuz'menko NV; Alexandrova LA; Chefu SG; Blashko EL; Zhloba AA; Cirlin VA
    Bull Exp Biol Med; 2011 May; 151(1):22-4. PubMed ID: 22442794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis.
    Moustapha A; Gupta A; Robinson K; Arheart K; Jacobsen DW; Schreiber MJ; Dennis VW
    Kidney Int; 1999 Apr; 55(4):1470-5. PubMed ID: 10201012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of homocysteine in end-stage renal disease.
    Wu CC; Zheng CM; Lin YF; Lo L; Liao MT; Lu KC
    Clin Biochem; 2012 Nov; 45(16-17):1286-94. PubMed ID: 22683753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homocysteine concentration changes after renal transplantation in children.
    Merouani A; Delvin EE; Genest J; Rozen R; Lambert M
    Pediatr Nephrol; 2002 Jul; 17(7):520-3. PubMed ID: 12172766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild hyperhomocysteinemia promotes renal hemodynamic dysfunction without histopathologic changes in adult rats.
    Ossani GP; Fischer PA; Caram SG; Dominguez GN; Monserrat AJ; Masnatta LD
    Kidney Int; 2004 Nov; 66(5):1866-72. PubMed ID: 15496157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The kidney and homocysteine metabolism.
    Friedman AN; Bostom AG; Selhub J; Levey AS; Rosenberg IH
    J Am Soc Nephrol; 2001 Oct; 12(10):2181-2189. PubMed ID: 11562419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and methionine metabolism in ESRD: A stable isotope study.
    van Guldener C; Kulik W; Berger R; Dijkstra DA; Jakobs C; Reijngoud DJ; Donker AJ; Stehouwer CD; De Meer K
    Kidney Int; 1999 Sep; 56(3):1064-71. PubMed ID: 10469375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of hyperhomocysteinemia to folic acid supplementation in patients with end-stage renal disease.
    Dierkes J; Domröse U; Ambrosch A; Bosselmann HP; Neumann KH; Luley C
    Clin Nephrol; 1999 Feb; 51(2):108-15. PubMed ID: 10069646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.